scholarly journals Horticultural therapy, nutrition and post-traumatic stress disorder in post-military veterans: developing non-pharmaceutical interventions to complement existing therapeutic approaches

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 885
Author(s):  
Richard Mottershead ◽  
Marjorie Ghisoni
Keyword(s):  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Stress Disorder ◽  
Mental Illnesses ◽  
Therapeutic Effects ◽  
Post Traumatic Stress ◽  
Horticultural Therapy ◽  
The Social ◽  
Post Traumatic ◽  
Pharmaceutical Interventions

Non-pharmaceutical interventions for veterans living with post-traumatic stress disorder are becoming a more popular way to address some of the social and personal needs identified by this group. Horticultural therapy or growing and eating food together provides several ways to increase mood, improve nutritional status, reduce loneliness and reduce the physical health impacts of mental illnesses such as post-traumatic stress disorder. In this paper we will discuss some of the issues people living with post-traumatic stress disorder might face. We will also provide an overview of the therapeutic effects of these approaches and how they will be applied in a locally identified group.

scholarly journals Making a medicine out of MDMA

2015 ◽  
Vol 206 (1) ◽  
pp. 4-6 ◽  
Author(s):  
Ben Sessa ◽  
David Nutt
Keyword(s):  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Clinical Utility ◽  
Stress Disorder ◽  
Therapeutic Potential ◽  
Mental Illnesses ◽  
Post Traumatic Stress ◽  
Treatment Resistant ◽  
The Past ◽  
Post Traumatic

SummaryFrom its first use 3,4,-methylenedioxymethamphetamine (MDMA) has been recognised as a drug with therapeutic potential. Research on its clinical utility stopped when it entered the recreational drug scene but has slowly resurrected in the past decade. Currently there is enough evidence for MDMA to be removed from its Schedule 1 status of ‘no medical use’ and moved into Schedule 2 (alongside other misused but useful medicines such as heroin and amphetamine). Such a regulatory move would liberate its use as a medicine for patients experiencing severe mental illnesses such as treatment-resistant post-traumatic stress disorder.

scholarly journals Current and novel pharmacological therapeutic approaches in Post-Traumatic Stress Disorder. A brief review

2021 ◽  
Vol 67 (3) ◽  
pp. 143-148
Author(s):  
Carmen-Maria Rusz ◽  
George Jîtcă ◽  
Amalia Miklos ◽  
Mădălina-Georgiana Bătrînu ◽  
Bianca Eugenia Ősz ◽  
...  
Keyword(s):  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Stress Disorder ◽  
Current Therapy ◽  
Cochrane Library ◽  
Systematic Research ◽  
Therapeutic Effects ◽  
Post Traumatic Stress ◽  
Therapeutic Approaches ◽  
Post Traumatic

Abstract Objective: Although not highly prevalent among the general population, post-traumatic stress disorder is a serious psychiatric condition, associated with co-morbidities, mortality and high suicide rates. Currently, there are few approved pharmacological therapies, which count as second-line, augmented to psychotherapy. Studies from the literature emphasize the need for novel treatment options, due to high relapse rates and patients that do not achieve remission. This study provides an overview over the pharmacological treatment of post-traumatic stress disorder, from a neurobiological perspective. Methods: A systematic research has been conducted through PubMed, PLOS one, Cochrane library and Google Scholar databases. Results: The neurobiological mechanisms which underlies the symptomatology are not fully elucidated. In the present, some theories involved in the onset/ manifestation are formulated (serotonergic, noradrenergic, glutamatergic, GABA-ergic, endocannabinoid) and the current therapy aims to modulate these neurotransmissions. In light of the studies along the years, a line should be drawn between the drugs acting on reducing the anxiety only and those that exhibit dual effect i.e. reducing the anxiety and affecting the memory reconsolidation processes. Although labelled as recreational drugs rather than compounds with intended therapeutic effects, cannabidiol and 3,4-methylenedioximethamphetamine appear to be the most promising from the perspective of efficacy and benefit-risk ratio. Conclusion: Preclinical studies come with acceptable results, yet clinical trials are controversial and heterogeneous, given the small population size. Given the seriousness of post-traumatic stress disorder, the attempts to find effective and safe treatment in a context that lacks appropriate therapeutic approaches should be encouraged.

Sign in / Sign up

Export Citation Format

Share Document